Aisling Capital Management as of June 30, 2026
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 14 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 72.5 | $342M | 4.6M | 74.48 | |
| Monte Rosa Therapeutics (GLUE) | 8.0 | $38M | 1.6M | 24.20 | |
| Syndax Pharmaceuticals (SNDX) | 6.1 | $29M | 1.3M | 21.86 | |
| Compass Pathways Sponsored Ads (CMPS) | 4.3 | $20M | 1.4M | 14.15 | |
| Bicara Therapeutics (BCAX) | 3.6 | $17M | 569k | 29.69 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 1.6 | $7.8M | 1.0M | 7.62 | |
| Scholar Rock Hldg Corp (SRRK) | 0.9 | $4.2M | 77k | 55.00 | |
| Urogen Pharma (URGN) | 0.8 | $4.0M | 108k | 36.80 | |
| Biomea Fusion (BMEA) | 0.6 | $3.0M | 2.0M | 1.47 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $2.3M | 435k | 5.29 | |
| Eupraxia Pharmaceuticals (EPRX) | 0.5 | $2.1M | 325k | 6.61 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.4 | $1.9M | 50k | 37.65 | |
| Marker Therapeutics Com New (MRKR) | 0.1 | $478k | 325k | 1.47 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.1 | $404k | 89k | 4.56 |
